Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kim, Soon Ae, Shim, Woo Ho, Lee, Eun Hae, Lee, Young Mi, Beom, Sun Hee, Kim, Eun Sook, Yoo, Jeong Seon, Nam, Ji Sun, Cho, Min Ho, Park, Jong Suk, Ahn, Chul Woo, Kim, Kyung Rae
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Diabetes Association 2011
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122893/
https://ncbi.nlm.nih.gov/pubmed/21738898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.159
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi